|
AAMP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.64070000041994E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.001500E-04 |
| Normal-vs-Stage2 |
1.004390E-04 |
| Normal-vs-Stage3 |
1.14810000395593E-08 |
| Normal-vs-Stage4 |
1.341790E-03 |
| Stage1-vs-Stage2 |
3.128300E-02 |
| Stage1-vs-Stage3 |
9.846800E-04 |
| Stage1-vs-Stage4 |
5.603400E-01 |
| Stage2-vs-Stage3 |
8.191000E-01 |
| Stage2-vs-Stage4 |
1.810770E-01 |
| Stage3-vs-Stage4 |
4.734100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34530000028832E-07 |
| Normal-vs-AfricanAmerican |
2.067000E-01 |
| Normal-vs-Asian |
1.032590E-01 |
| Caucasian-vs-AfricanAmerican |
2.050100E-02 |
| Caucasian-vs-Asian |
8.255600E-01 |
| AfricanAmerican-vs-Asian |
5.591000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.33779995362227E-09 |
| Normal-vs-Female |
2.630400E-02 |
| Male-vs-Female |
4.9063999999488E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.96240000000559E-05 |
| Normal-vs-Age(41-60Yrs) |
2.17149999999222E-05 |
| Normal-vs-Age(61-80Yrs) |
3.274899999961E-06 |
| Normal-vs-Age(81-100Yrs) |
2.570200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.964640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.457800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.420400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.417000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.664800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.566400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.314400E-01 |
| Normal-vs-Grade 2 |
8.07980000000486E-05 |
| Normal-vs-Grade 3 |
1.93962999999187E-05 |
| Normal-vs-Grade 4 |
8.47540000403768E-08 |
| Grade 1-vs-Grade 2 |
7.710400E-02 |
| Grade 1-vs-Grade 3 |
5.898200E-02 |
| Grade 1-vs-Grade 4 |
3.355500E-03 |
| Grade 2-vs-Grade 3 |
5.461400E-01 |
| Grade 2-vs-Grade 4 |
1.053930E-02 |
| Grade 3-vs-Grade 4 |
4.453800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.183700E-02 |
| Normal-vs-ccB subtype |
1.63524749297039E-12 |
| ccA subtype-vs-ccB subtype |
5.27355936696949E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.27539999952953E-07 |
| Normal-vs-N1 |
2.760500E-03 |
| N0-vs-N1 |
8.127200E-01 |
|
|
